Planned Rule 144 sale of LRCX common stock
A holder of common stock of LRCX has filed a notice of proposed sales under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A holder of common stock of LRCX has filed a notice of proposed sales under Rule 144. The filing lists up to 18,282 shares, with an indicated aggregate market value of $6,124,470.00, to be sold through Fidelity Brokerage Services LLC on or after July 13, 2026 on the NASDAQ market.
The shares relate to prior restricted stock vesting events received from the issuer as compensation on several dates between 2014 and 2025.
Filing Explained
The July 13 filing lists 18,282 common shares for sale, but documents neither a completed sale nor a new Lam Research issuance.
The
Because the filing identifies the securities as shares to be sold, rather than a new company issuance, it does not document added shares or proceeds for Lam Research.
The listed shares are attributed to restricted-stock vesting and compensation: 6,012 shares dated
The “Securities Sold During The Past 3 Months” section contains no reported transaction in the supplied text, so the filing provides no completed-sale amount to add to the 18,282 shares listed for sale.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock vesting financial
aggregate market value financial
compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for LRCX disclose?
AI-generated analysis. How Rhea-AI works. Not financial advice.